Current therapeutic management of diabetic nephropathy

URN to cite this document:: urn:nbn:de:bvb:355-epub-220384
DOI to cite this document:: 10.5283/epub.22038

Kohler, S. M. ; Krämer, Bernhard K.

Preview

PDF
(800kB)

Date of publication of this fulltext: 08 Sep 2011 10:14

Alternative links to fulltext:Pubmed

Details

Preview

Export bibliographical data

Abstract

Roughly 40% of all patients with insulin-dependent diabetes mellitus (IDDM) develop diabetic nephropathy with proteinuria, hypertension and a decrease in glomerular filtration rate 10 to 20 years after the onset of the disease, and 5 years later most patients suffer from end-stage renal disease. Microalbuminuria, defined as an urinary albumin excretion rate (UAER) between 30 and 300 mg/day, ...